Preserving renal function in adults with hypertension and diabetes

A consensus approach

G. L. Bakris, M. Williams, L. Dworkin, W. J. Elliott, M. Epstein, R. Toto, K. Tuttle, J. Douglas, W. Hsueh, J. Sowers, K. Willis

Research output: Contribution to journalArticle

1161 Citations (Scopus)

Abstract

Over 11 million Americans have both diabetes and hypertension - comorbid diseases that strongly predispose people to both renal as well as cardiovascular (CV) injury. Hypertension substantially contributes to CV morbidity and mortality in people with diabetes. Diabetes is the most common cause of end-stage renal disease in the United States. Furthermore, hypertension and diabetes are particularly prevalent in certain populations, such as African-Americans and Native Americans. Since the 1994 Working Group Report on Hypertension and Diabetes, a large body of clinical trial data has affirmed the original blood pressure goal of less than 130/85 mmHg recommended to preserve renal function and reduce CV events in people with hypertension and diabetes. Data that are more recent have emerged, however, to support an even lower diastolic blood pressure goal, ie, 80 mmHg, in order to optimally preserve renal function and reduce CV events in people with diabetic nephropathy. A review of clinical trials indicates that more than 65% of people with diabetes and hypertension will require two or more different antihypertensive medications to achieve the new suggested target blood pressure of 130/80 mmHg. The purpose of this report is to update the previous recommendations with a focus on level of blood pressure control, proteinuria reduction, and therapeutic approaches to achieve these goals. We provide an evidence-based approach, integrating data from the major clinical trials that were designed as randomized prospective, long-term studies that had as a primary endpoint either progression of diabetic nephropathy or reduction in CV events. This report also addresses socioeconomic and cultural barriers that hinder achievement of blood pressure goals. Lastly, the report discusses approaches to resolve cultural barriers, both physician- and patient-derived, that interfere with achievement of lower blood pressure goals. (C) 2000 by the National Kidney Foundation, Inc.

Original languageEnglish (US)
Pages (from-to)646-661
Number of pages16
JournalAmerican Journal of Kidney Diseases
Volume36
Issue number3
StatePublished - 2000

Fingerprint

Consensus
Blood Pressure
Hypertension
Kidney
Diabetic Nephropathies
Clinical Trials
North American Indians
Proteinuria
African Americans
Antihypertensive Agents
Chronic Kidney Failure
Morbidity
Physicians
Mortality
Wounds and Injuries
Population

Keywords

  • Albuminuria
  • Diabetes
  • Guidelines
  • Hypertension
  • Nephropathy
  • Proteinuria

ASJC Scopus subject areas

  • Nephrology

Cite this

Bakris, G. L., Williams, M., Dworkin, L., Elliott, W. J., Epstein, M., Toto, R., ... Willis, K. (2000). Preserving renal function in adults with hypertension and diabetes: A consensus approach. American Journal of Kidney Diseases, 36(3), 646-661.

Preserving renal function in adults with hypertension and diabetes : A consensus approach. / Bakris, G. L.; Williams, M.; Dworkin, L.; Elliott, W. J.; Epstein, M.; Toto, R.; Tuttle, K.; Douglas, J.; Hsueh, W.; Sowers, J.; Willis, K.

In: American Journal of Kidney Diseases, Vol. 36, No. 3, 2000, p. 646-661.

Research output: Contribution to journalArticle

Bakris, GL, Williams, M, Dworkin, L, Elliott, WJ, Epstein, M, Toto, R, Tuttle, K, Douglas, J, Hsueh, W, Sowers, J & Willis, K 2000, 'Preserving renal function in adults with hypertension and diabetes: A consensus approach', American Journal of Kidney Diseases, vol. 36, no. 3, pp. 646-661.
Bakris, G. L. ; Williams, M. ; Dworkin, L. ; Elliott, W. J. ; Epstein, M. ; Toto, R. ; Tuttle, K. ; Douglas, J. ; Hsueh, W. ; Sowers, J. ; Willis, K. / Preserving renal function in adults with hypertension and diabetes : A consensus approach. In: American Journal of Kidney Diseases. 2000 ; Vol. 36, No. 3. pp. 646-661.
@article{bf64425d44ad498eadfe5a06e907f2ab,
title = "Preserving renal function in adults with hypertension and diabetes: A consensus approach",
abstract = "Over 11 million Americans have both diabetes and hypertension - comorbid diseases that strongly predispose people to both renal as well as cardiovascular (CV) injury. Hypertension substantially contributes to CV morbidity and mortality in people with diabetes. Diabetes is the most common cause of end-stage renal disease in the United States. Furthermore, hypertension and diabetes are particularly prevalent in certain populations, such as African-Americans and Native Americans. Since the 1994 Working Group Report on Hypertension and Diabetes, a large body of clinical trial data has affirmed the original blood pressure goal of less than 130/85 mmHg recommended to preserve renal function and reduce CV events in people with hypertension and diabetes. Data that are more recent have emerged, however, to support an even lower diastolic blood pressure goal, ie, 80 mmHg, in order to optimally preserve renal function and reduce CV events in people with diabetic nephropathy. A review of clinical trials indicates that more than 65{\%} of people with diabetes and hypertension will require two or more different antihypertensive medications to achieve the new suggested target blood pressure of 130/80 mmHg. The purpose of this report is to update the previous recommendations with a focus on level of blood pressure control, proteinuria reduction, and therapeutic approaches to achieve these goals. We provide an evidence-based approach, integrating data from the major clinical trials that were designed as randomized prospective, long-term studies that had as a primary endpoint either progression of diabetic nephropathy or reduction in CV events. This report also addresses socioeconomic and cultural barriers that hinder achievement of blood pressure goals. Lastly, the report discusses approaches to resolve cultural barriers, both physician- and patient-derived, that interfere with achievement of lower blood pressure goals. (C) 2000 by the National Kidney Foundation, Inc.",
keywords = "Albuminuria, Diabetes, Guidelines, Hypertension, Nephropathy, Proteinuria",
author = "Bakris, {G. L.} and M. Williams and L. Dworkin and Elliott, {W. J.} and M. Epstein and R. Toto and K. Tuttle and J. Douglas and W. Hsueh and J. Sowers and K. Willis",
year = "2000",
language = "English (US)",
volume = "36",
pages = "646--661",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Preserving renal function in adults with hypertension and diabetes

T2 - A consensus approach

AU - Bakris, G. L.

AU - Williams, M.

AU - Dworkin, L.

AU - Elliott, W. J.

AU - Epstein, M.

AU - Toto, R.

AU - Tuttle, K.

AU - Douglas, J.

AU - Hsueh, W.

AU - Sowers, J.

AU - Willis, K.

PY - 2000

Y1 - 2000

N2 - Over 11 million Americans have both diabetes and hypertension - comorbid diseases that strongly predispose people to both renal as well as cardiovascular (CV) injury. Hypertension substantially contributes to CV morbidity and mortality in people with diabetes. Diabetes is the most common cause of end-stage renal disease in the United States. Furthermore, hypertension and diabetes are particularly prevalent in certain populations, such as African-Americans and Native Americans. Since the 1994 Working Group Report on Hypertension and Diabetes, a large body of clinical trial data has affirmed the original blood pressure goal of less than 130/85 mmHg recommended to preserve renal function and reduce CV events in people with hypertension and diabetes. Data that are more recent have emerged, however, to support an even lower diastolic blood pressure goal, ie, 80 mmHg, in order to optimally preserve renal function and reduce CV events in people with diabetic nephropathy. A review of clinical trials indicates that more than 65% of people with diabetes and hypertension will require two or more different antihypertensive medications to achieve the new suggested target blood pressure of 130/80 mmHg. The purpose of this report is to update the previous recommendations with a focus on level of blood pressure control, proteinuria reduction, and therapeutic approaches to achieve these goals. We provide an evidence-based approach, integrating data from the major clinical trials that were designed as randomized prospective, long-term studies that had as a primary endpoint either progression of diabetic nephropathy or reduction in CV events. This report also addresses socioeconomic and cultural barriers that hinder achievement of blood pressure goals. Lastly, the report discusses approaches to resolve cultural barriers, both physician- and patient-derived, that interfere with achievement of lower blood pressure goals. (C) 2000 by the National Kidney Foundation, Inc.

AB - Over 11 million Americans have both diabetes and hypertension - comorbid diseases that strongly predispose people to both renal as well as cardiovascular (CV) injury. Hypertension substantially contributes to CV morbidity and mortality in people with diabetes. Diabetes is the most common cause of end-stage renal disease in the United States. Furthermore, hypertension and diabetes are particularly prevalent in certain populations, such as African-Americans and Native Americans. Since the 1994 Working Group Report on Hypertension and Diabetes, a large body of clinical trial data has affirmed the original blood pressure goal of less than 130/85 mmHg recommended to preserve renal function and reduce CV events in people with hypertension and diabetes. Data that are more recent have emerged, however, to support an even lower diastolic blood pressure goal, ie, 80 mmHg, in order to optimally preserve renal function and reduce CV events in people with diabetic nephropathy. A review of clinical trials indicates that more than 65% of people with diabetes and hypertension will require two or more different antihypertensive medications to achieve the new suggested target blood pressure of 130/80 mmHg. The purpose of this report is to update the previous recommendations with a focus on level of blood pressure control, proteinuria reduction, and therapeutic approaches to achieve these goals. We provide an evidence-based approach, integrating data from the major clinical trials that were designed as randomized prospective, long-term studies that had as a primary endpoint either progression of diabetic nephropathy or reduction in CV events. This report also addresses socioeconomic and cultural barriers that hinder achievement of blood pressure goals. Lastly, the report discusses approaches to resolve cultural barriers, both physician- and patient-derived, that interfere with achievement of lower blood pressure goals. (C) 2000 by the National Kidney Foundation, Inc.

KW - Albuminuria

KW - Diabetes

KW - Guidelines

KW - Hypertension

KW - Nephropathy

KW - Proteinuria

UR - http://www.scopus.com/inward/record.url?scp=0033852481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033852481&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 646

EP - 661

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 3

ER -